Attovia Therapeutics, Inc. (ATTO)

Attovia Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Attovia Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	-0.04	-0.05	-
Debt / EBITDA Ratio	-0.07	-0.08	-
Debt / FCF Ratio	-0.08	-0.09	-
Net Debt / Equity Ratio	1.02	1.37	1.48
Net Debt / EBITDA Ratio	1.82	2.21	1.61
Net Debt / FCF Ratio	2.00	2.39	1.88
Quick Ratio	13.53	13.83	8.98
Return on Equity (ROE)	51.10%	56.43%	85.00%
Return on Assets (ROA)	-	-36.55%	-51.88%
Return on Invested Capital (ROIC)	-	-60.00%	-60.23%
Return on Capital Employed (ROCE)	724.15%	-43.42%	-62.67%